
In my research I aim to combine structural, biophysical and computational investigations into an integrated experimental approach to the determination and analysis of protein structure and to understand this information in the light of its biological context. The evolution of high-throughput structural biology means that the determination of protein structure can now more often be the origin of functional hypotheses, rather than play its more traditional role as the explicative end of protein analysis. In pioneering a higher throughput platform for structural biology in New Zealand, I have been aiming to make the structural analysis of proteins a routine endeavour in molecular biology. Structural genomics, perhaps more correctly called structural proteomics, sets out to apply genomic-scale technologies to the determination of three-dimensional protein structure, with the aim of increasing the output of structural biology. An important outcome of this approach is to increase the availability of protein structural analysis to the molecular biology community. The development of this technological platform also enables several fundamental questions about the relationship between protein sequence and protein structure to be addressed: How many distinct protein structural types exist in nature? Is it possible to model the structures of all protein families? Can we use structural information to determine or predict the functions of otherwise uncharacterised gene products? One of the ongoing challenges is the experimental exploitation of structure-derived predictions about protein function. I have used a combination of structural and computational analyses to identify a deeply conserved but previously uncharacterised family of proteins as adenosine-specific binding proteins with a likely kinase activity (Lott et al., 2006), illustrating the kind of biochemical knowledge that can be deduced from structural information. This structure-first approach can also be applied to problems of medical relevance. I have also had success with proteins from the pathogen Mycobacterium tuberculosis which are either validated targets for the design of new anti-bacterial agents or proteins likely to be important to the bacterium in its unique niche. Anthranilate phosphoribosyl transferase catalyses the second step in tryptophan biosynthesis, and has been identified by genetic knock-out as essential for pathogenesis. Its structure identified conformational changes associated with the binding of one substrate which enabled the correct prediction of how the second substrate binds and how the reaction is likely to occur - essential information for the identification and future design of inhibitors (Lee et al., 2006). I also have an ongoing collaboration with Fiona McDonald at the University of Otago in which structural and biophysical analyses are being used to investigate mechanisms of regulation of the human epithelial sodium channel, in particular by the ubiquitin ligases of the Nedd4 family, and by the so far poorly understood protein Murr1/COMMD1. Current work includes the determination by NMR of the high affinity interaction between the binding domain of Nedd4 and its target sequence in the channel, and biophysical characterisation of Murr1/COMMD1 and related proteins. Recent Publications2006ANTHONY HARRISON, ROCHELLE RAMSAY, EDWARD N. BAKER & J. SHAUN LOTT J. SHAUN LOTT, BLAKE PAGET, JODIE M. JOHNSTON, LOUIS T. J. DELBAERE, JILL A. SIMON-SIGRELL, MARK J. BANFIELD, AND EDWARD N. BAKER VICKERY L. ARCUS, J. SHAUN LOTT, JODIE M. JOHNSTON & EDWARD N. BAKER CLARE LEE, CATHERINE GOODFELLOW, FARAH JAVID-MAJD, EDWARD N. BAKER & J. SHAUN LOTT 2005CELIA J. WEBBY, HEATHER M. BAKER, J. SHAUN LOTT, EDWARD N. BAKER & EMILY J. PARKER. NICOLE MORELAND, RACHAEL ASHTON, HEATHER M. BAKER, IVAN IVANOVIC, SEAN PATTERSON, VICKERY L. ARCUS, EDWARD N. BAKER & J. SHAUN LOTT MIRIAM L. SHARPE, EDWARD N. BAKER & J. SHAUN LOTT CELIA J. WEBBY, J. SHAUN LOTT, HEATHER M. BAKER, EDWARD N. BAKER & EMILY J. PARKER ANTHONY J. HARRISON, ROCHELLE J. RAMSAY, EDWARD N. BAKER & J. SHAUN LOTT SIMON LI, NEIL A. PETERSON, MIN-YOUNG KIM, CHANG-YUB KIM, LI-WEI HUNG, MINMIN YU, TIMOTHY LEKIN, BRENT W. SEGELKE, J. SHAUN LOTT & EDWARD N. BAKER 2004J. SHAUN LOTT & EDWARD N. BAKER 2003J. SHAUN LOTT, MARK J. BANFIELD, JILL A. SIGRELL, EDWARD N. BAKER. EDWARD N. BAKER, VICKERY L. ARCUS AND J. SHAUN LOTT |
Sponsors
|